“Digital health” is an umbrella term that’s grown to include everything from electronic health records to wellness apps and clinically validated therapeutic interventions that mirror or improve upon existing in-person therapies. Digital therapeutics (DTx) deliver evidence-based therapeutic interventions to patients that are driven by high quality software programs to prevent, manage, or treat a medical disorder or disease. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes. DTx products incorporate advanced technology best practices relating to design, clinical validation, usability, and data security. They are reviewed and cleared or approved by regulatory bodies as required to support product claims regarding risk, efficacy, and intended use
The global digital therapeutics (DTx) market is mainly driven by rising prevalence of chronic diseases, growing geriatric population and significant increase in venture capital investments. Partnerships between companies & clinical institutions for R&D activities are also playing a pivotal role in triggering the market growth globally. However, risk of cybersecurity threats, data privacy concerns of patients, limited awareness and accessibility to digital therapeutics programs in emerging countries, resistance from traditional healthcare providers, and unstable payment models are some of the key challenges that are likely to hinder the growth of the market to a certain extent.
The global digital therapeutics (DTx) market has been analyzed from three main perspectives: Application, Distribution Channel and Region.
Based on application, the digital therapeutics (DTx) market has been segmented into obesity, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, respiratory diseases, smoking cessation and others (skin related disorders, blood related disorders, immunological disorders, cancer, musculoskeletal disorders, etc.). The diabetes segment accounted for the largest share in the market. Patients with chronic diseases like diabetes, require significant changes in lifestyle, regular vigilance, and care. The growth of the segment can be attributed to its growing prevalence, rising awareness regarding the importance of health management in diabetes and incessant launch of digital therapeutic products & solutions with innovative features.
Based on type of commercial transaction, the digital therapeutics (DTx) market has been segmented into B2B and B2C. The B2B segment holds the largest share and is expected to be the fastest growing segment during the forecast period. The growth of the segment can mainly be attributed to growing awareness among providers, payors, and employers regarding the benefits provided by digital therapeutics including additional benefit of cost-effectiveness.
Based on region, the global digital therapeutics (DTx) market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). North America dominated the digital therapeutics (DTx) market, followed by Asia Pacific. The large share of North America in the global market can largely be attributed to the rising prevalence of various lifestyle related diseases such as obesity & diabetes, presence of key prominent players, launch of new products and rising investment for development of digital therapeutics technology.
The digital therapeutics (DTx) market is marked by presence of prominent players such as Voluntis, Teladoc Health, Inc., Omada Health, Inc., 2Morrow Inc., Pear Therapeutics, Inc., Ginger, ResMed, CANARY HEALTH, Welldoc, Proteus Digital Health, Inc. Other players operating in the market are MedRhythms, Merck & Co., Inc., Akili Interactive Labs, Inc., GAIA AG, Click Therapeutics, Inc., among others.
|Market Size Period||2018-2031|
|Market Segments||Asessment of Digital Therapeutics Market By:
• Commercial Transaction
|Geographic Scope||• North America
◦ Rest of Europe (RoE)
• Asia Pacific
◦ Rest of Asia Pacific (RoAPAC)
• Rest of the World
◦ Latin America
◦ Middle East & Africa
|Companies Covered||Voluntis, Teladoc Health, Inc., Omada Health, Inc., 2Morrow Inc., Pear Therapeutics, Inc., Ginger, ResMed, CANARY HEALTH, Welldoc, Proteus Digital Health, Inc., MedRhythms, Merck & Co., Inc., Akili Interactive Labs, Inc., GAIA AG, Click Therapeutics, Inc., among others.|
1 RESEARCH ENVELOPE
1.1 Market Classification
1.2 Scope of the Study
1.2.1 Timeline Considered for Market Study
· Historic Years – 2018 & 2019
· Base Year – 2020
· Projected Years – 2021 to 2031
1.3 Currency Used in the Report
2 RESEARCH METHODOLOGY
2.1 Research Approach
2.2 Data Collection Methodology
2.3 Data Sources
2.3.1 Secondary Sources
2.3.2 Primary Sources
2.4 Market Crackdown Methodology
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Data Forecasting Model
2.6 Limitations and Assumptions for Study
3 HEADWINDS & TAILWINDS ASSESSMENT
4 MARKET OPPORTUNITIES ASSESSMENT
5 PREMIUM INSIGHTS
5.1 Key Market Trends
5.2 Key Players & Their Competitive Positioning (2020)
5.3 COVID-19 Impact Assessment
6 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY APPLICATION
6.3 Central Nervous System (CNS) Disorders
6.4 Cardiovascular Diseases
6.5 Respiratory Diseases
6.6 Smoking Cessation
6.7 Other Applications (Skin Related Disorders, Blood Related Disorders, Immunological Disorders, Cancer, Musculoskeletal Disorders, Etc.)
7 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY TYPE OF COMMERCIAL TRANSACTION
8 GLOBAL DIGITAL THERAPEUTICS (DTX) MARKET, BY REGION
8.1 North America Digital Therapeutics (DTx) Market
8.1.1 North America Digital Therapeutics (DTx) Market, By Country
8.1.2 North America Digital Therapeutics (DTx) Market, By Application
8.1.3 North America Digital Therapeutics (DTx) Market, By Type of Commercial Transaction
8.2 Europe Digital Therapeutics (DTx) Market
8.2.1 Europe Digital Therapeutics (DTx) Market, By Country/Region
18.104.22.168 Rest of Europe (ROE)
8.2.2 Europe Digital Therapeutics (DTx) Market, By Application
8.2.3 Europe Digital Therapeutics (DTx) Market, By Type of Commercial Transaction
8.3 Asia Pacific Digital Therapeutics (DTx) Market
8.3.1 Asia Pacific Digital Therapeutics (DTx) Market, By Country/Region
22.214.171.124 Rest of Asia Pacific (RoAPAC)
8.3.2 Asia Pacific Digital Therapeutics (DTx) Market, By Application
8.3.3 Asia Pacific Digital Therapeutics (DTx) Market, By Type of Commercial Transaction
8.4 Rest of the World (RoW) Digital Therapeutics (DTx) Market
8.4.1 Rest of the World Digital Therapeutics (DTx) Market, By Region
126.96.36.199 Latin America
188.8.131.52 Middle East & Africa
8.4.2 Rest of The World Digital Therapeutics (DTx) Market, By Application
8.4.3 Rest of The World Digital Therapeutics (DTx) Market, By Type of Commercial Transaction
9 COMPANY PROFILES
9.1.1 Business Overview
9.1.2 Financial Metrics*
9.1.3 Product Portfolio
9.1.4 Key Developments
9.2 Teladoc Health, Inc.
9.3 Omada Health, Inc.
9.4 2Morrow Inc.
9.5 Pear Therapeutics, Inc.
9.8 CANARY HEALTH
9.10 Proteus Digital Health, Inc.
*Insights on financial metrics is subject to availability of information in the public domain
3D printing also known as additive manufacturing is a process of making three dimensional solid objects from a CAD model or a digital 3D model. The term "3D printing" can refer to a variety of proc...
Hemophilia is a rare inherited bleeding disorder in which the blood does not clot properly which leads to spontaneous bleeding as well as bleeding following injuries or surgery. Blood contains prot...
The term halal is particularly associated with Islamic dietary laws and especially meat processed & prepared in accordance with those requirements. Halal is an Arabic word that means permissible. H...
Urinalysis is a test & analysis of urine to detect and manage a wide range of disorders, namely urinary tract infections, kidney disease and diabetes, among others. It includes a group of physical,...
Allergy is an exaggerated reaction by the immune system in response to exposure to certain foreign substances. These foreign substances are called as allergens and includes pollens, dust mites, mol...
Micro-catheters are a broad term, often used to describe thin wall, small diameter catheters and delivery devices used in minimally invasive applications. Its small build makes it ideal for navigat...
Remote patient monitoring (RPM) is a subset of telehealth. It is a technology that enables monitoring of patients outside of conventional clinical settings.
Femtech is a term applied to a category of software, diagnostics, products and services that focus on women's health.
Telehealth is a broader array of digital healthcare activities & services and can be defined as distribution of health-related services & information including medical care, provider & patient educ...
Sleep apnea is a condition where breathing is interrupted during sleep. It is considered a serious sleep disorder in which breathing repeatedly stops and starts.
A MedTech CDMO is a company that serves other companies in the medical device industry on contract basis and provides comprehensive services ranging from design & development, prototyping, tooling,...
Wearable medical devices are electronic devices that are designed to collect the data of users' personal health and exercise. It offers a convenient means of monitoring many physiological features,...
A contract research organization (CRO) also known as a clinical research organization, is an organization that provides services to pharmaceutical, biotechnology, and medical device companies.
Cell and gene therapy (CGT) companies partner with CGT CDMOs to get support on discovery, preclinical, clinical stages, CGT product development, manufacturing, and commercial manufacturing.